Results 161 to 170 of about 36,054 (205)
Some of the next articles are maybe not open access.

Vaccines for papillomavirus infection

Virus Research, 2002
Vaccines to prevent PV infection, utilising PV L1 virus like particles (VLPs) to induce neutralising antibody, are in clinical trial and show all the characteristics likely to be associated with success. Results warrant global planning for the deployment of VLP vaccines within a decade, as part of a program to prevent cervical cancer. Vaccines designed
openaire   +5 more sources

Human Papillomavirus and Vaccination

Mayo Clinic Proceedings, 2008
Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States. Modeling estimates suggest that more than 80% of sexually active women will have acquired genital HPV by age 50 years. Although most infections are transient and asymptomatic, persistent infection with high-risk types of HPV can lead to ...
openaire   +2 more sources

The human papillomavirus vaccine

Journal of the American Academy of Dermatology, 2008
Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Warren R. Heymann, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the ...
openaire   +2 more sources

Vaccination Against Papillomavirus in Cattle

Clinics in Dermatology, 1994
Papillomaviruses are oncogenic viruses, involved in the induction of squamous cell carcinomas. The evidence for this is incontrovertible in animals and extremely strong in the human subject. Experimental reproduction of cancer induced by papillomavirus has been achieved in cattle and rabbits (Campo and Jarrett 1986; Campo et al.
openaire   +3 more sources

Human papillomavirus vaccination in adolescence

Perspectives in Public Health, 2013
Cervical cancer is the third most common female cancer worldwide. It remains the highest ranking preventable cancer affecting women in developing countries. Cervical cancer is caused by sexual transmission of human papillomavirus (HPV). It is estimated that more than 80% of sexually active women will be infected with HPV in their lifetime, usually in ...
Michelle, Russell   +2 more
openaire   +2 more sources

Human Papillomavirus Vaccination

New England Journal of Medicine, 2023
Lauri E, Markowitz, Elizabeth R, Unger
openaire   +2 more sources

Human papillomavirus vaccines and adolescents

Current Opinion in Obstetrics & Gynecology, 2005
This review will describe human papillomavirus (HPV) vaccines in development, summarize data regarding safety and efficacy of these vaccines, and discuss key issues related to HPV vaccine implementation.Evidence from epidemiologic and genetic studies has confirmed that HPV infection is a necessary cause of cervical cancer and contributes to the ...
Jessica A, Kahn, David I, Bernstein
openaire   +2 more sources

Human papillomavirus vaccine update

Current Infectious Disease Reports, 2007
With the approval of Gardasil (Merck and Co., Inc., Whitehouse Station, NJ) in June of 2006 and the pending approval of Cervarix (GlaxoSmithKline, London, UK), two prophylactic human papillomavirus (HPV) vaccines will be available for clinical use. Randomized controlled trials have shown that both vaccines are safe and highly effective in preventing ...
Alisa, Ames, Patti, Gravitt
openaire   +2 more sources

Human Papillomavirus Vaccine Update

Primary Care: Clinics in Office Practice, 2015
This article provides an overview of human papillomavirus (HPV) infection and the burden of HPV-related diseases, including cervical cancer, in the United States. The article presents an overview of HPV vaccination, including the efficacy and safety of the HPV vaccine, recommendations for vaccination in the adolescent population, as well as points to ...
openaire   +2 more sources

Human papillomavirus disease and vaccines

American Journal of Health-System Pharmacy, 2008
Human papillomavirus (HPV) disease and vaccines and several controversial issues associated with vaccine administration are reviewed.HPV infection is the most common sexually transmitted disease in the United States. It is estimated that 20 million individuals are currently infected with HPV, with 6.2 million new infections occurring each year ...
David J, Hutchinson, Kristin C, Klein
openaire   +2 more sources

Home - About - Disclaimer - Privacy